SHANGHAI, Sept. 18, 2013 /PRNewswire/ -- Organized by CPhI Conferences and UBM Conferences, 2013 Pharmaceutical Intellectual Property Forum will take place on 27th-28th November at Sheraton HongKou, Shanghai. This forum will deliver themes which will optimize IP strategy. This conference aims to provide a platform to facilitate exchange of experience, and encourage more cooperation between Pharmaceutical & Biotech Companies, Law firms and IP Agencies. It will walk away with fresh insights, tactics and tools to apply for patents, strategize litigation techniques and remain competitive in today's constantly changing patent landscape. Hear from experts, meet potential collaborators and gather insights to re-align IP strategy. To download full agenda, please click to www.pharmaip-forum.com.
Meanwhile, the organizer shared with us with two excellent presentations about pharmaceutical intellectual property. One was the topic "Global Pharmaceutical Market Outlook: 2015." This presentation is mainly about the quantification of the impact of multiple dynamics and examining the spending and usage of medicines in 2015, globally and for specific therapy areas and countries. The other one was about "Pharma Licensing - Case Studies & Pointers," shared by Dr. Richie Paul, the Director of Intellectual Property from Elan Drug Technologies. He analysed 4 cases and proposed that technology providers could play a role in both enabling NCE-based products and lifecycle Management. If you are interested in them, please CLICK HERE to download for free.
If you cannot download successfully, please use this link:
Ms. Tracy Cui
Tel: +86-21-6157 3919
Email: [email protected]
SOURCE UBM Conferences